The study was evaluating Mirati’s therapy sitravatinib in combination with Bristol-Myers...
Featured articles
"At this stage, it appears possible that unexpectedly high corticosteroid use in the INTEREST...
The most common complaints for the drug in the study was hypertension
The trial examined the combination of nelipepimut-S (NeuVax, NPS) and trastuzumab (Herceptin) in...
The company's lead drug, SD-101 is being evaluated for its safety and activity
This month, the Anesthetic and Analgesic Drugs Products Advisory Committee voted 10-3 in favor...
Featured companies
Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune disea...
Clinigen Group plc is a rapidly-growing global pharmaceutical and services company with a uniq...
Callitas Health Inc: (OTCQB: MPHMF) OTC & Pharma R&D company focused on sexual wellnes...
Tumour Trace is dedicated to developing innovative, patented cancer screening and diagnostic t...
Sphere Medical is a dynamic company specialising in the development of innovative medical moni...
BetterCells Ltd is a private company and has ambitions to list on a major securities exchange.
Global biotech Newswire
The study was evaluating Mirati’s therapy sitravatinib in combination with Bristol-Myers...
The EU is also requesting more information on overall survival rates for patients in the study
"At this stage, it appears possible that unexpectedly high corticosteroid use in the INTEREST...
The most common complaints for the drug in the study was hypertension
The trial examined the combination of nelipepimut-S (NeuVax, NPS) and trastuzumab (Herceptin) in...
The company's lead drug, SD-101 is being evaluated for its safety and activity
The cannabis company has acquired Buddy’s Cannabis for an undisclosed amount
This month, the Anesthetic and Analgesic Drugs Products Advisory Committee voted 10-3 in favor...
The aim of part two is to study the efficacy and safety of the SNG001 inhaler in up to 120 COPD...
Executive video interviews
Francois Martelet, chief executive of NetScientific PLC (LON:NSCI), spoke to Proactive...
Faz Chowdhury, chief executive of Nemaura Medical Inc (NASDAQ:NMRD), spoke to Proactive...
Aethlon Medical Inc (NASDAQ:AEMD) CEO Jim Joyce spoke with Proactive Investor's...
Berlin Cures Holding AG President Joannes Müller and COO Peter Göttel sit down with...
Hillstream BioPharma CEO Randy Milby sits down with Proactive Investors' Christine...
Bryan Oronsky and James Brown from EpicentRx sit down with Christine Corrado at the BIO...
ChemioCare USA Inc CEO Pedro Lichtinger sits down with Proactive Investors' Christine...
Epygen Group President Debayan Ghosh sits down with Christine Corrado at the BIO...
Zynerba Pharmaceuticals (NASDAQ:ZYNE) CEO Armando Anido caught up with Proactive...
Michael Hunt, CFO at Reneuron Plc (LON:RENE), spoke to Proactive ahead of new data being...
Veravas CEO John Forrest sits down with Proactive Investors' Christine Corrado at the...
Dr. Reddy’s Laboratories Ltd (NYSE:RDY) Senior Vice President Anil Namboodiripad spoke...
Big picture investment ideas in Biotech Capital
In its recent half-year results, the medical research investor recorded a loss after tax of...
Respiratory syncytial virus causes the common cold, for which there is no effective cure.
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO...
The broker says the cancer treatment developer could potentially take the entire share of the...
The biotech group revealed it had brought in $9.1mln via an oversubscribed placing
HemoGenyx said it was pleased with the opportunities that had been unlocked for its CDX...
WideCells has undertaken a review of the business to deliver a strategy that will generate...
The pharma group expects to dose the first patient in the Phase III trial of its MED2002...
The drug developer had originally to recruit 80 people for the second part of its phase II study...
Capital Network Research
Avacta Group - Maximising Affimer's potential across therapeutics and...
October 03 2018
Over the last year or so, management has delivered significant progress in bringing their...
Judges Scientific PLC - 2018 Interim Results
September 21 2018
Judges Scientific reported results for the first half of 2018. The period included a...
Legendary Investments - Hidden value potential
September 03 2018
Legendary Investments (LON:LEG) creates value through privately held and pre-market...
Avacta Group - Exciting partnership with Bach BioSciences
July 30 2018
Avacta Group Plc (LON:AVACT) has recently finalised a co-development partnership with...
Avacta Group - Rapid Progress of Immuno-oncology Programs
April 16 2018
KEY INVESTOR MESSAGES
Faster than expected development of the second immuno-oncology...
Summit Therapeutics Plc - Stock Valuation Undemanding
April 03 2018
- Key inflection point: topline data readout from the PhaseOut DMD phase 2 trial in Duchenne...
Partners:
